The MHRA make it clear: the UK will take a backseat in EU’s medicine licensing regime post-Brexit
Sarah-Jane Dobson
On 18 February 2020, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA), updated its guidance on medicine licensing post-Brexit “Apply for a licence to market a medicine in the UK”. The update provides further clarity on the UK’s status in the licensing process now that Brexit has taken place.
8 for 8: UK Government accepts key recommendations to reform recall and product safety regimes
In January 2018, the UK’s Department for Business, Energy and Industrial Strategy (“BEIS”) provided its much-awaited response to proposals for reform to the product safety and product recall regimes.
Sea change: UK government bans plastic microbeads from cosmetics products
Jamie Humphreys and Fergal Duggan
On 9 January 2018, the UK introduced a ban on the manufacture or supply of products containing microbeads, following a worldwide trend towards greater oversight of plastic pollution. The ban will affect manufacturers of a wide range of cosmetics products, including face scrubs, toothpastes and shower gels.